6.08
Sana Biotechnology Inc stock is currently priced at $6.08, with a 24-hour trading volume of 1.89M.
It has seen a -14.97% decreased in the last 24 hours and a -29.30% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $7.01 pivot point. If it approaches the $6.35 support level, significant changes may occur.
Previous Close:
$7.15
Open:
$7.02
24h Volume:
1.89M
Market Cap:
$1.35B
Revenue:
-
Net Income/Loss:
$-283.26M
P/E Ratio:
-3.2169
EPS:
-1.89
Net Cash Flow:
$-273.61M
1W Performance:
-12.89%
1M Performance:
-29.30%
6M Performance:
+52.38%
1Y Performance:
-3.49%
Sana Biotechnology Inc Stock (SANA) Company Profile
Name
Sana Biotechnology Inc
Sector
Industry
Phone
206 701 7914
Address
188 East Blaine Street, Suite 400, Seattle
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-16-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
Sep-25-23 | Initiated | JMP Securities | Mkt Outperform |
Sep-05-23 | Initiated | Citigroup | Buy |
Aug-14-23 | Initiated | TD Cowen | Market Perform |
May-02-23 | Initiated | H.C. Wainwright | Neutral |
Mar-01-21 | Initiated | BofA Securities | Buy |
Mar-01-21 | Initiated | Goldman | Neutral |
Mar-01-21 | Initiated | JP Morgan | Neutral |
Mar-01-21 | Initiated | Morgan Stanley | Overweight |
View All
Sana Biotechnology Inc Stock (SANA) Latest News
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 5.2% - MarketBeat
MarketBeat
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace
BioSpace
Sana Biotechnology Inc [SANA] Shares Fall -1.02 % on Wednesday – Knox Daily - Knox Daily
Knox Daily
Sana Biotechnology Inc Stock (SANA) Financials Data
Sana Biotechnology Inc (SANA) Net Income 2024
SANA net income (TTM) was -$283.25 million for the quarter ending December 31, 2023, a -5.11% decrease year-over-year.
Sana Biotechnology Inc (SANA) Cash Flow 2024
SANA recorded a free cash flow (TTM) of -$273.61 million for the quarter ending December 31, 2023, a +12.00% increase year-over-year.
Sana Biotechnology Inc (SANA) Earnings per Share 2024
SANA earnings per share (TTM) was -$1.47 for the quarter ending December 31, 2023, a -2.80% decline year-over-year.
About Sana Biotechnology Inc
Sana Biotechnology, Inc. develops and delivers engineered cells as medicine for patients. It identifies and develops potential product candidates; and executes preclinical studies. The company develops technologies to repair and control genes in cells; and replace any cell in the body. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was founded in 2018 and is based in Seattle, Washington with additional offices in South San Francisco, California; and Cambridge, Massachusetts.
Cap:
|
Volume (24h):